Navigate Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$747K Sell
633
-37
-6% -$37.8K 0.46% 36
2026
Q1
$605K Buy
+670
New +$679K 0.43% 37

Other funds holding LLY

Navigate Wealth Management's LLY Position: Q2 2026 in Review

Navigate Wealth Management reduced its Eli Lilly (LLY) stake by 5.5% in Q2 2026, selling an estimated $37.8K and leaving 633 shares worth $747K. The position accounts for 0.46% of the portfolio, ranked #36.

Navigate Wealth Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,584 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Navigate Wealth Management held 633 shares of Eli Lilly worth $747K as of Q2 2026.
  • Navigate Wealth Management sold 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 0.46% of Navigate Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Navigate Wealth Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,584 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Navigate Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.